Lindsay A. Rosenwald
2016
In 2016, Lindsay A. Rosenwald earned a total compensation of $2M as Chairman, President and Chief Executive Officer at Fortress Biotech, a 34% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $500,000 |
|---|---|
| Salary | $29,689 |
| Stock Awards | $1,492,285 |
| Other | $12,020 |
| Total | $2,033,994 |
Rosenwald received $1.5M in stock awards, accounting for 73% of the total pay in 2016.
Rosenwald also received $500K in non-equity incentive plan, $29.7K in salary and $12K in other compensation.
Rankings
In 2016, Lindsay A. Rosenwald's compensation ranked 4,815th out of 14,075 executives tracked by ExecPay. In other words, Rosenwald earned more than 65.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,815 out of 14,075 | 66th |
Division Manufacturing | 1,714 out of 5,486 | 69th |
Major group Chemicals And Allied Products | 533 out of 1,900 | 72nd |
Industry group Drugs | 393 out of 1,543 | 75th |
Industry Pharmaceutical Preparations | 311 out of 1,173 | 74th |
Source: SEC filing on April 26, 2017.
Rosenwald's colleagues
We found three more compensation records of executives who worked with Lindsay A. Rosenwald at Fortress Biotech in 2016.